INTRODUCTION
Many metals are essential for life, due primarily to their capacity to mediate electron transfer in a multitude of biochemical reactions, from oxygen transport to primary mitochondrial function.
Evolutionary processes have resulted in elegant metal chaperoning mechanisms to restrict unwanted reactions that can precipitate cell damage, such as iron (Fe)-mediated oxidative stress [1] . However, the industrial revolution introduced the release of toxic heavy metals and otherwise essential metals, such as zinc (Zn), into the environment at a rate unparalleled in human history [2, 3] . These excessive environmental exposures have the potential to overwhelm the finite capacity which the human body has evolved to compensate for, which may result in a significant risk of toxicity to the human body, and particularly to the developing child.
Both animal studies and epidemiological surveys have demonstrated that the early-life period, spanning from conception through childhood, represents a critical window of heightened susceptibility to metal exposures [4] . The precise reasons why certain metal exposures can cause significant long-term negative health outcomes are often unclear, which is something that contemporary analytical chemistry is now in a prime position to address. Elemental bioimaging, wherein a range of imaging modalities can be used to generate low-tosubmicron scale, quantitative images of the spatial distributions of metal species, is an emerging technology with the potential to revolutionize the study of metal exposure biology. This review will briefly discuss the techniques available and how they can be implemented into wider-scale epidemiological studies of early-life metal exposures. We will also discuss the diversity of information that imaging provides, including the capacity to retrospectively assess metal exposures using novel biomarkers and investigate maternal-fetal transfer through placental tissues, and, finally, we will speculate on the potential of immunohistochemical methods to study both metal exposures and associated biological response factors.
THE PLACENTA AS A WINDOW INTO FETAL EXPOSURE
Here, we focus on the placenta as a useful matrix for monitoring metal exposures in children that are particularly suited for bioimaging [5] . The placenta has great potential for exposure assessment as an indicator of maternal-fetal transfer of metals and the resultant biological responses.
As the sole barrier between mother and fetus, the placenta regulates the transfer of nutrients, essential biomolecules, and wastes between the mother and child through passive and active transport mechanisms, while providing some degree of protection against toxins. It is not impervious to all harmful chemical species and it is particularly permeable to industrial toxins and chemicals [6] , including heavy metals. Although the precise mechanisms through which heavy metals actively cross the placental barrier remain unclear, it is likely that these otherwise foreign trace metals usurp the roles of evolutionarily conserved methods for the transfer of essential elements to the developing fetus. Lead (Pb), for instance, is able to utilize existing mechanisms for Fe homeostasis to disperse throughout the human body, including across the placenta [7, 8] . Even excessive exposure to otherwise essential metals can compromise the placental barrier, for example, high manganese (Mn) concentrations have been observed in placental tissues from children with neural tube defects [9] . In addition, the placenta itself exhibits immune and endocrine functions that are critical for a healthy pregnancy, which can be perturbed by adverse environmental exposures [10] , possibly including heavy metals [11, 12] . Given the accessibility and ease of placental tissue sample collection following birth, the placenta is a valuable yet underutilized target tissue to monitor in-utero metal exposures at the maternal/fetal interface, though ample consideration must be given to the effects of long-term formalin storage on metal content and distribution [13] , and, where possible, age-matched (in terms of storage) samples should be used.
IMAGING BIOLOGICAL EXPOSURES
A number of techniques are available for imaging metals in biological matrices, ranging from traditional histochemistry to synchrotron-based microprobes (see reviews by McRae et al. [14] and Hare et al. [15 && ] for comprehensive overviews of technologies available). Here, we discuss three of the most widely used techniques, and we provide a brief overview of additional techniques that have not yet been used to image metals in matrices relevant to children's health, but have the potential to provide additional resources.
Laser ablation-inductively coupled plasmamass spectrometry
Laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) was first used to image metals in biological samples by Wang et al. [16] in 1994. This technique uses a focused laser beam that is rastered across a sample surface, generating a stream of ablated particles that are detected in real time by an ICP-MS and used to generate spatial maps of metal distributions [17] . LA-ICP-MS has achievable detection limits for some elements as low as 10 ng/g [14] , and it is particularly sensitive to heavy metals because of their high atomic masses and low environmental background levels. LA-ICP-MS instruments are now capable of producing 1 mm spatial resolution images [18] , though sensitivity for ultratrace elements is restricted when the volume of the ablated sample is reduced to this level.
LA-ICP-MS has been used extensively to study the distribution of metals in various biological tissues to assess both concentrations and distributions [19 & ], though few applications have directly addressed exposure assessment. LA-ICP-MS was used to study uranium (U), plutonium (Pu), and thorium (Th) exposure in lymphatic tissue from ex-nuclear workers years after suffering acute occupational exposures [20] , and background levels of Th and U in human hippocampus tissue was proposed as a possible internal standard for measuring endogenous metals in tissue [21] , though this approach fails to meet contemporary guidelines for internal standardization for LA-ICP-MS because of each element's extremely low abundance [17, 22] .
X-ray fluorescence microscopy
X-ray fluorescence microscopy (XFM) uses energetic hard X-ray beams (>10 keV), generated by the brilliant light sources obtained from synchrotrons, for the high-resolution mapping of element concentrations in biological samples that takes advantage of the characteristic electronic properties of each element. A detailed description of the principles behind XFM and a selection of biological applications can be found in the review by Pushie et al. [23] . The major advantage of XFM is the high spatial resolution, which is now well below subcellular resolution following recent upgrades at the Advanced Photon Source in the USA, the European Synchrotron Radiation Facility in France, and the SPRing-8 synchrotron in Japan. As in LA-ICP-MS, the potential of this technique for imaging exposure biology in children's tissue has not been fully exploited, though a range of applications to exposure biology in both environmental and adult health applications is summarized in the review by Paunesku et al. [24] .
In the first step toward the integration of XFM imaging in epidemiologic birth cohort studies, Punshon and colleagues [25 && ] recently demonstrated for the first time the feasibility of XFM imaging in human placental chorionic villi specimens. An example of the application of XFM imaging in formalin-fixed, paraffin-embedded human placental tissue is shown in Fig. 1 . Here, we used traditional immunohistochemistry to identify localized areas of inflammation (CD68þ and CD66bþ cells) in chorionic villi, and we mapped element distributions in one of these regions in an adjacent tissue section using XFM.
The potential of XFM is limited by access; only around 40 synchrotron facilities have been constructed worldwide, each with differing capabilities and beamlines are often oversubscribed with high access costs and highly competitive application procedures. Regardless, the continuing improvements to XFM technology enables the probing of metal distributions at nanoscale resolution while maintaining sensitivity [26] , which is paramount for assessing the toxicity of metals that occur at extremely low concentrations.
Particle-induced X-ray emission
Particle (or proton) induced X-ray emission spectroscopy (PIXE) operates according to similar principles as XFM, though rather than using a hard X-ray source, highly energetic particles are directed onto a sample in a vacuum, resulting in the same innershell electron ejection and emission of characteristic fluorescence observed in XFM. As for XFM, PIXE has superior resolution to LA-ICP-MS, but is also less accessible. PIXE has, however, long been used for assessing heavy metal concentrations following environmental exposure in relevant tissues, such as bone [27] . Again, few examples in the literature specifically describe the use of PIXE in the analysis of tissue relevant to children's health, though there are abundant studies demonstrating the capacity of this technique for imaging metals.
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BEYOND METALS: IMAGING PROTEIN-METAL ASSOCIATIONS
Imaging metals tell part of the story in exposure biology. Other factors, including transport proteins and biologic effect markers, are equally as important for understanding metal toxicity as the metal itself. Several recent studies have demonstrated the utility of immunohistochemical methods employing antibodies labelled with exogenous metal tags, combined with elemental imaging, as a novel approach to associate specific metal distributions with a protein, peptide, or enzyme of interest [28, 29] . In Fig. 2 , we show how labelling of heat shock protein 70, a marker of stress, in the placenta with europium-tagged antibodies shows the spatial association of heat shock protein 70 with areas of high Mn concentration, a known redox-active metal and source of increased oxidative stress at high concentrations. Not only can metal-tagged antibodies be used to identify associations between metals and biologically relevant proteins but also can be used to identify rare yet important cell types in a number of chronic diseases [30] , which may have implications for rare diseases in children. Although most immunohistochemical approaches rely on secondary antibodies to amplify the signal for target detection, the sensitive nature of elemental imaging allows the direct use of metal-tagged primary antibodies, thus enabling the development of highly multiplexed imaging methods. Giesen et al. [31 && ] used a particularly elegant method employing fast-scanning and highresolution laser ablation coupled to a CyTOF (a modified ICP-MS typically used for flow, or in this case 'mass' cytometry) to simultaneously image 32 individual antigens in human breast cancer samples, each labelled with a monoisotopic rare earth element, which delineated unique cell subpopulation phenotypes associated with patient classifications. Continued development of this technology, in line with the integration of the validated standard operating procedures typical of clinical biochemistry, presents a promising future for elemental imaging in the coming decades.
CONCLUSION
The technological capacity has been in place for some time, but only now is the medical research community embracing the potential of tissue imaging for uncovering the roles of metals in disease processes. Nowhere is this more relevant than exposure biology; considering the expanding knowledge regarding critical windows of susceptibility to environmental exposures and chronic disease risk later in life, elemental imaging of placentas and other relevant tissues has the potential to make a substantial impact on children's environmental health research. Increased interdisciplinary collaboration between the chemists and physicists who develop these methods and the biologists and clinicians who can most benefit from them, will increase the use of this technology into epidemiologic and clinical research. This opinion piece is intended to make the contemporary pediatrician and pediatric researcher aware of how these technologies may be integrated into their field, in the hope that greater
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